Belite Bio, INC (BLTE) SEC Filings — 2024

Filings

• Belite Bio Files November 2024 6-K Report — 6-K · Nov 12, 2024
• Belite Bio Files Form 6-K for November 2024 — 6-K · Nov 4, 2024
• Belite Bio Appoints New Chief Medical Officer — 6-K · Sep 3, 2024
• Belite Bio Files August 2024 6-K Report — 6-K · Aug 9, 2024
• Belite Bio Files 6-K Report — 6-K · May 14, 2024
• Belite Bio Prices $3M Direct Offering of ADSs and Warrants — 6-K · Apr 26, 2024
• Belite Bio Submits Tinlarebant Trial to Japan's PMDA — 6-K · Mar 22, 2024
• Belite Bio, Inc. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Mar 12, 2024
• Lin Bioscience Discloses Significant Stake in Belite Bio — SC 13G · Feb 12, 2024